Literature DB >> 8124917

False positive ELISA serologic test for Lyme borreliosis in patients with connective tissue diseases.

B Keymeulen1, G Somers, A Naessens, L A Verbruggen.   

Abstract

Three patients are reported with false positive enzyme-linked immunosorbent assay (ELISA) for IgG antibodies against Borrelia burgdorferi, respectively associated with undifferentiated connective tissue disease or systemic lupus erythematosus. These cases further document that Lyme serology should be interpreted with caution and within the clinical context.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8124917     DOI: 10.1007/bf02231784

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  16 in total

Review 1.  Epidemiology, clinical features, and diagnosis of Lyme disease.

Authors:  J D Cooper; R T Schoen
Journal:  Curr Opin Rheumatol       Date:  1992-08       Impact factor: 5.006

2.  Comparative evaluation of three products for the detection of Borrelia burgdorferi antibody in human serum.

Authors:  R D Fister; L A Weymouth; J C McLaughlin; R W Ryan; R C Tilton
Journal:  J Clin Microbiol       Date:  1989-12       Impact factor: 5.948

3.  False positive serologic tests for Lyme disease after varicella infection.

Authors:  H M Feder; M A Gerber; S W Luger; R W Ryan
Journal:  N Engl J Med       Date:  1991-12-26       Impact factor: 91.245

4.  Frequency and specificity of antibodies that crossreact with Borrelia burgdorferi antigens.

Authors:  P T Fawcett; K M Gibney; C D Rose; S B Dubbs; R A Doughty
Journal:  J Rheumatol       Date:  1992-04       Impact factor: 4.666

5.  Diagnosing Lyme disease: the contribution of serologic testing.

Authors:  J Duffy; L E Mertz; G H Wobig; J A Katzmann
Journal:  Mayo Clin Proc       Date:  1988-11       Impact factor: 7.616

6.  Enzyme-linked immunosorbent assay and indirect immunofluorescence assay for Lyme disease.

Authors:  H Russell; J S Sampson; G P Schmid; H W Wilkinson; B Plikaytis
Journal:  J Infect Dis       Date:  1984-03       Impact factor: 5.226

7.  Cross-reactivity of nonspecific treponemal antibody in serologic tests for Lyme disease.

Authors:  L A Magnarelli; J N Miller; J F Anderson; G R Riviere
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

8.  Lyme disease: clinical features, classification, and epidemiology in the upper midwest.

Authors:  W Agger; K L Case; G L Bryant; S M Callister
Journal:  Medicine (Baltimore)       Date:  1991-03       Impact factor: 1.889

Review 9.  Lyme disease.

Authors:  A C Steere
Journal:  N Engl J Med       Date:  1989-08-31       Impact factor: 91.245

10.  [Borrelia infection and systemic lupus erythematosus].

Authors:  K Federlin; H Becker
Journal:  Immun Infekt       Date:  1989-12
View more
  5 in total

Review 1.  Systemic lupus erythematosus.

Authors:  M S Klein-Gitelman; M L Miller
Journal:  Indian J Pediatr       Date:  1996 Jul-Aug       Impact factor: 1.967

2.  Determination of tetanus antibodies by a double-antigen enzyme-linked immunosorbent assay in individuals of various age groups.

Authors:  K Caglar; R Karakus; C Aybay
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-08       Impact factor: 3.267

3.  [CXCL-13 as a biomarker in the diagnostics of neuroborreliosis].

Authors:  C Waiß; W Kindler; B Ströbele; C Aspöck; S Oberndorfer
Journal:  Nervenarzt       Date:  2017-06       Impact factor: 1.214

Review 4.  Immunoserological Diagnosis of Human Borrelioses: Current Knowledge and Perspectives.

Authors:  Emilie Talagrand-Reboul; Alice Raffetin; Pierre Zachary; Benoît Jaulhac; Carole Eldin
Journal:  Front Cell Infect Microbiol       Date:  2020-05-19       Impact factor: 5.293

5.  An intervention in general practice to improve the management of Lyme borreliosis in Denmark.

Authors:  Fredrikke Christie Knudtzen; Thøger Gorm Jensen; Nanna Skaarup Andersen; Isik Somuncu Johansen; Joppe W Hovius; Sigurdur Skarphédinsson
Journal:  Eur J Public Health       Date:  2022-06-01       Impact factor: 4.424

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.